Stocks and InvestingStocks and Investing
Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021
Thu, June 10, 2021
Wed, June 9, 2021
Tue, June 8, 2021

Andrew Fein Maintained (BIIB) at Strong Buy with Increased Target to $452 on, Jun 8th, 2021


Published on 2024-10-27 16:55:43 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $305 to $452 on, Jun 8th, 2021.

Andrew has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 2 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $245 on, Monday, April 12th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Decreased Target to $268 on, Wednesday, February 17th, 2021


This is the rating of the analyst that currently disagrees with Andrew


  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $325 on, Tuesday, May 18th, 2021